Spain to Stop Darias Vaccinating in Mechanism Drug

“AstraZeneca has been given many millions of doses around the world. And about twenty cases of thrombosis have been described. For the moment, the drug regulatory agencies have not raised the alarm.”

He believes that the decision of certain countries and communities in Spain to stop vaccinating with this drug is another “mechanism for the population”, so that there is no “panic” to get the vaccine. Although he warns that the vaccination plan can be delayed: “AstraZeneca is very easy to put in, if you don’t put it in, the process can be delayed a lot.”

The Minister of Health, Carolina Darias, pointed out this Friday that the AstraZeneca batch withdrawn in other countries due to alleged thrombotic episodes and which is being investigated was already supplied and administered in Spain, so “it is not about stopping a batch” that Spain does not have. Also the World Health Organization (WHO) says that “there is no reason” to stop using this drug.

Although the European Medicines Agency has insisted this week in its preliminary analysis that at the moment “there is no evidence” that the AstraZeneca vaccine causes conditions related to thrombosis, several Member States have opted directly to temporarily suspend the administration of this antidote or at least paralyze the pricks with the vaccines from a specific batch (ABV5300) distributed in 17 Member States, including Spain.

This is the case of Austria, Denmark, Estonia, Lithuania, Luxembourg, Latvia and this Friday also Bulgaria (in addition to Iceland and Norway).

Italy for its part has paralyzed the injections of another batch (ABV2856), after several deaths in Sicily. Despite growing doubts in some countries, as of Wednesday according to the EMA, only 30 cases of thrombosis-related conditions had been reported among the 5 million people vaccinated with the AstraZeneca antidote, a number that is not higher than can be achieved. see in the general population.

The European regulator’s safety committee (PRAC) has launched an in-depth investigation to review all cases of thromboembolism reported after the injection of covid vaccines and, if necessary, will make recommendations to minimize the risks.

In an interview in RNE and when asked if a specific monitoring of the people inoculated with this batch will be activated, Darias explained that the Ministry and the Spanish Agency for Medicines carry out a “permanent” pharmacovigilance monitoring since any vaccine is administered, so no specific process will be launched because the one that exists is already “very powerful”.

Darias has insisted that the AstraZeneca vaccine is “safe” and so says the European Medicines Agency (EMA), which has shown that “there is no causal relationship between the thrombotic event and the vaccine itself.” Therefore, it has reiterated the message of “prudence and tranquility” and maximum vigilance.

Regarding the fact that the EMA has given itself 14 days to establish a general recommendation on the vaccination of AstraZeneca and if Spain is finally going to apply it to people over 55 years of age, Darias has said that the Government will give itself “a waiting period.” depending on what the EMA says “and from there we will act.”

As decided in mid-February by the Public Health Commission , the AstraZeneca vaccine is being administered to essential workers under the age of 55 (firefighters, teachers, police and some non-frontline health workers , among others), who will be followed by the population generally between 45 and 55 years old.

The minister has also referred to the vaccination of the child population and has indicated that as long as there are no clinical trials or evidence, “this vaccination cannot be carried out” and recalled that the EMA technical file is from 18 years of age. . In the case of pregnant women, Darias has considered that, for now, it will only be carried out under medical prescription.

Fear of the side effects of the AstraZeneca vaccine corner the pharmaceutical company that sees how several countries have decided to suspend vaccination with these doses. The last one, Thailand , which this Friday chose to postpone vaccination against COVID-19 with Oxford-AstraZeneca, the day after some European countries did the same due to its possible adverse effects.

The suspension for two weeks was announced in extremis at a press conference in which in principle they planned to report on the start of the vaccination with the drug that was going to have the Thai Prime Minister, Prayut Chan-ocha , and other ministers among the first inoculated.

“We have to delay vaccination with AstraZeneca,” said the Thai government adviser on vaccination against covid-19, Piyasakol Sakolsatayadorn, who said the decision was made after the temporary suspension announced in Denmark.

37000 AstraZeneca vaccines with the Exception

Catalonia has withdrawn the batch of AstraZeneca vaccines that are allegedly related to some cases of thrombosis detected in Denmark and Austria, according to sources from the Ministry of Health.

Salut has already administered 37,000 AstraZeneca vaccines, with the exception of these 2,000 doses that have already been withdrawn “for prevention and pending a report from the European Medicines Agency (EMA).”

“The Department of Health maintains the vaccination plan planned for the following weeks,” say these sources. Communities such as Andalusia, Asturias and Castilla-León have decided, directly, to suspend vaccination with the British antidote.

We do these contents thanks to you. If you want to receive the best El Periódico content in your email, subscribe to our exclusive newsletters for registered users.

The experts consulted by this newspaper defend the safety of AstraZeneca. The epidemiologist Joan Guix, former secretary of the Public Health Agency (Aspcat), insists that there is no evidence that cases of thrombosis are related to this vaccine, but that countries such as Denmark or Austria have stopped immunization for “precaution”.

“We have guarantees that the vaccine has passed all the safety phases, but now what is on the march are the reactions that there may be. And that is done with all drugs,” says Guix.

“The benefit is greater than the possible side effects. Those over 60 years of age are much more likely to have complications from covid,” he adds.

The same is said by the Head of Infectious Diseases at the Vall d’Hebron Hospital, Benito Almirante. “With the measles vaccine, out of every million doses, there is a child who has encephalitis.

But without it, measles would affect one in 10,000 children. The benefit is much greater. Even though the causality of AstraZeneca with thrombi can be demonstrated That would not prevent vaccination “, defends Almirante, who nevertheless believes that these cases have been” incidental. “

Mollerussa of up to nine points in Newspaper in Borras

During the electoral campaign, in this newspaper we explained that it was in the eight main towns that are located along the Eix Transversal where the duel between Aragonès and Borràs was to be decided.

A check on the opinion of the voters of these localities allows us to verify that, in effect, the difference between ERC and JxCat is now smaller, although the Republicans only awarded the ‘sorpasso’ to the post-convergent, and by the hair, in Lleida capital : Junts took two tenths from Esquerra in 2017 and now Esquerra, who grew, has taken 7 tenths from Junts, which decreased.

The hosts of Aragonès in Cervera were on the verge of overturning , where they reduced the advantage of JxCat from 11.5 to only 2.8 points, mainly because the Puigdemontistas fell 7 points compared to 2017. In Igualada both lost steam, but more Borràs, who dropped six points, so the Junts lead was cut in half and now stands at 4.7 points. Greater was the post-convergent fall in Mollerussa of up to nine points, which caused the distance over ERC to go from 16 to 6 points.

Manresa and Tàrrega repeated the same scheme, but with more contained descents from JxCat. In Girona capital , Junts’ advantage over Esquerra was three points lower than in 2017, although it is still very significant, at 15.4%.

Nothing compared, however, with the cushion that the Puigdemontistas have in Vic , a historic convergent bastion, where Aragonès left three points and Borràs, only two, with which the difference between the two forces climbed to 22 points.

The other scale that the electoral victory was going to decide was located in the Barcelona conurbation, among other things because it concentrated the highest percentage of undecided . The PSC regained the strength it had lost, but ERC advanced significantly and came second in 28 of the 36 towns in the metropolitan area, and ahead of the Socialists in two of them, Molins de Rei and Sant Cugat del Vallès .

The voting differences between Socialists and Republicans ranged between 3 points in Sant Vicenç dels Horts , the town of Oriol Junqueras, and 26 points in Santa Coloma de Gramenet , so the average difference was around 15 points. In the city of Barcelona , the distance in favor of the PSC was 4.5 points, when ERC had beaten it by 6.4 points in the 2017 elections.

Independence Movement Two Colors Continue in 2017

The two blocks that underpinned the independence process are still reflected on the map of Catalonia after the regional elections of February 14. But the color gamut has varied on both sides.

The non-secessionist electorate relied heavily on Ciutadans in 2017 and has now largely re-migrated to the socialist fishing ground.

From orange to red. In the independence movemen two colors continue to predominate and their presence has been balanced after an electoral call that has given control of the ‘procés’ to ERC for the first time.

In fact, the Republicans last Sunday achieved the double challenge that they had set themselves in these elections to cut the distance with the PSC in the metropolitan area of ​​Barcelona and with JxCat in the inland regions of Catalonia. Happiness was not complete because socialists and postconvergents maintain their hegemony in these areas.

Salvador Illa’s socialists won the elections with almost 50,000 votes more than ERC and more than 80,000 over JxCat, and they are the only party that obtained more support than in 2017 (Vox aside).

But it is the first time that the winning formation does not reach 25% of the votes (it remained at 22.7%). The PSC obtained its best result since 2006 and the 104 municipalities where it was imposed represent more than 60% of the census.

The metropolitan area of ​​Barcelona, ​​the coast of Tarragona and the Vall d’Aran were its main fiefdoms, but it faltered again in inland Catalonia. His best record was in La Llagosta (43.9%) and the worst, in Anglesola (2.6%).

14M Succeed in Times Of 248 Towns

The Republican candidate, Pere Aragonès , reaped the second best result of ERC alone in a regional election and tied for seats with the PSC. However, he lost one in three voters compared to the 2017 elections.

He won in 248 towns a hundred more than three years before, and consolidated his primacy in the south of the country and in Lleida. He also managed to gain ground from the socialists in the metropolitan area and JxCat in Girona and central Catalonia, but without too many ‘surprises’. The highest percentage of voting for Esquerra was in Cervià de les Garrigues (43.2%) and the lowest in Bossòst (10.1%).

For its part, Junts per Catalunya, with Carles Puigdemont and Laura Borràs at the helm, was the leading force in six out of 10 municipalities in Catalonia, but they were a hundred less than in 2017.

If compared to CiU, JxCat recorded the worst result in a post-convergence Catalan election, remaining below 20% of the votes and losing one in three supporters compared to the previous elections.

The province of Girona continues to be the great fortress of Junts, with Amer, the hometown of Puigdemont , as the municipality where it obtained the highest percentage of ballots (58.9%). At the other extreme, Badia del Vallès, where only 2.9% voted for them.